Membrane fluidity and thromboxane synthesis in platelets from patients with severe atherosclerosis.

TitleMembrane fluidity and thromboxane synthesis in platelets from patients with severe atherosclerosis.
Publication TypeJournal Article
Year of Publication1986
AuthorsMoscat J, Perez P, Gavilanes FG, Acin F, Schüller A, Municio AM
JournalThromb Res
Date Published1986 Oct 15
KeywordsAged, Arachidonic Acid, Arachidonic Acids, Arteriosclerosis, Blood Platelets, Chromatography, High Pressure Liquid, Fluorescence Polarization, Humans, Lipids, Male, Membrane Fluidity, Middle Aged, Thrombin, Thromboxane A2, Thromboxane B2, Thromboxanes, Tritium

Platelets play an important role in the development of atherosclerosis. The arachidonic acid, whose oxygenated metabolites are potent regulators of the platelet-vessel wall interactions, is released from membrane phospholipids by the phospholipase (s) system (s). These membrane-linked phenomena are strongly modulated by the membrane physical properties. The present study was carried out to investigate the relationship between membrane fluidity and arachidonic acid metabolism in platelets from atherosclerotic patients. Twenty-one patients with peripheral vascular disease and twelve controls were studied. Platelets from patients showed an increase in membrane fluidity and enhanced thrombin-stimulated thromboxane synthesis. No alterations were found, however, in total phospholipid fatty acid composition. A significant decrease in the cholesterol/phospholipid ratio could account for the alterations in the membrane physical properties described in the platelets from patients.

Alternate JournalThromb Res
PubMed ID3097871
Related Faculty: 
Jorge Moscat, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700